SEATTLE, May 26, 2021, (MEDGADGET) — Androgen Replacement Therapy or low testosterone treatment is normally known as hormone replacement therapy for men. It is intended to check the impacts of decreased movement in the hypogonadism i.e. the genitals. Hypogonadism in men is a clinical condition which brings about the disappointment of the testicles to deliver physiological degrees of testosterone. The main reason of hypogonadism might be an issue with the testicles. The secondary reason is that an issue with the nerve center or pituitary organ or both essential and optional. Essential hypogonadism is caused because of testicular trauma, genetic abnormalities, radiation treatment or chemotherapy or orchitis, while auxiliary hypogonadism is caused by hypothalamus and genetic abnormalities of the pituary gland. Implants, gels, oral implantations and creams are used for the treatment of hypogonadism. Patients can utilize the medicine according to their accommodation.
Get Sample PDF (Including COVID-19 Impact Analysis, Full TOC, Tables and Figures) of Androgen Replacement Therapy, https://www.coherentmarketinsights.com/insight/request-pdf/3787
The market of androgen replacement therapy is projected to reach US$ 1,736.9 million in 2020, rising at a CAGR of 3.7 percent over the forecast period (2020-2027).
The demand for androgen replacement therapy is expected to increase as the prevalence of hypogonadism rises and new products are introduced
The raising occurrence of hypogonadism in grown-up men is expected to drive development of the androgen replacement therapy market. As indicated by the European Association of Urology: 2016 report, among moderately aged men, the occurrence of hypogonadism shifts from 2.1% to 12.8%. In Europe, the rate of low testosterone and manifestations of hypogonadism in men in the age gathering of 40 to 79 fluctuates from 2.1% to 5.7%. Hypogonadism is more common in man with obesity, older men, those with poor health status and those with co-morbidities. Moreover, as per the Therapeutics Advances of Urology Journal: 2016, testosterone was quite possibly the most broadly prescribed prescriptions in the U.S. in 2011. This has brought about development of androgen substitution treatment from US$ 18 million out of 1980 to US$ 1.6 billion out of 2011 which was a five-overlay increment.
Besides, product launches by market players are expected to foster the growth of androgen replacement therapy market development soon. For example, in April 2019, Israeli generics organization, Teva Pharmaceutical Industries (Teva), declared the dispatch of genetic versions of AndroGel (testosterone gel) 1.62% CIII and VESIcare (solifenacin succinate) tablets, 5 mg and 10 mg, in the U.S. Testosterone gel 1.62% CIII is shown for swap treatment in grown-up guys for conditions related with absence or inefficiency of endogenous testosterone, which incorporate inherent or gained essential hypogonadism and inborn or obtained hypogonadotropic hypogonadism.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/3787
Restraints:
Nonetheless, development of the androgen replacement therapy market might be hampered due to the expanding item reviews of testosterone items on the lookout. For example, in August 2018, the U.S. auxiliary of Sun Pharmaceutical Industries Ltd reviewed in excess of 5,215 units of 10 ml vials of testosterone cypionate injections, in the strength of 200 mg/ml from the U.S. market, the most recent implementation report of review was requested by the U.S. Food and Drug Administration (US FDA). As indicated by the U.S.FDA report, the progressing intentional cross country review is a Class II review, started in a circumstance. The product was reviewed because of its chance causing impermanent or medicinally reversible adverse health consequences.
Regional Analysis:
North America represented the largest share in the androgen replacement therapy market in 2019, due to incraesing number of product launches in the U.S. For example, in October 2018, the Perrigo Company Plc. reported the dispatch of an AB-appraised conventional rendition of Androgel Topical Gel, 1.62% (20.25mg testosterone/1.25g bundle, 40.5mg testosterone/2.5g parcel, and 20.25mg/1.25g activation siphon). At conventional generic market development, an unrelated outsider has dispatched an approved generic version. Androgel Topical Gel, 1.62% is shown for trade treatment in guys for conditions related with the absence or inefficiency of endogenous testosterone.
Moreover, organizations in the market are focusing in on obtaining permit arrangements to acquire business rights for a specific country which is relied upon to drive development of the androgen substitution treatment market in Asia Pacific. For example, in December 2016, Acerus Pharmaceuticals Corporation declared the consenting to of an arrangement giving selective option to showcase NATESTO in South Korea to Hyundai Pharm Co. Ltd., a South Korean drug organization. NATESTO is the sole testosterone nasal gel for androgen trade treatment in grown-up guys for conditions related with a lack or nonattendance of endogenous testosterone (hypogonadism).
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/androgen-replacement-therapy-market-3053
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Active Ingredient Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Merger and Acquisition
- Product Launches
- PEST Analysis
- Regulatory Scenario
- Schedule III controlled substances
- S. FDA regulations associated with risks of abuse and dependence of testosterone and other anabolic androgenic steroids (AAS)
- Exempt chemical preparations
- Use of anabolic steroids and associated implications
- Pipeline Analysis
- Market Dynamics
- Global Androgen Replacement Therapy Market – Impact of Coronavirus (Covid-19) Pandemic
- COVID-19 Epidemiology
- Overall Impact Assessment
- Supply Side And Demand Side Analysis
- Impact of COVID-19 on Androgen Replacement Therapy Patients
- Government Recommendations
- Global Androgen Replacement Therapy Market, By Product Type, 2017-2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Testosterone Creams/Gels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Testosterone Patches
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Testosterone Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Testosterone Implants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Testosterone Tablets/Capsules/Gums
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Androgen Replacement Therapy Market, By Active Ingredient Type, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Testosterone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Methyl Testosterone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Testosterone Undecanoate
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Testosterone Enanthate
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Testosterone Cypionate
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Androgen Replacement Therapy Market, By Distribution Channel, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Androgen Replacement Therapy Market, By Region, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2018 – 2028
- Regional Trends
- North America
- Market Size and Forecast, By Product Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Active Ingredient Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Product Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Active Ingredient Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Product Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Active Ingredient Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Active Ingredient Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Product Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Active Ingredient Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Product Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Active Ingredient Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country/Region, 2017 – 2028 (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
Other Related Reports:
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837